Replies to post #24035 on Cel Sci Corporation (CVM)

[Mogles]

Not a short, been long 10 years, never sold a single share. My point is that this is biotech investing, there are lots of ways a clinical trial can be derailed. You’re correct that the IDMC would have stopped it if they noticed anything troubling. Hopefully the next IDMC meeting is positive as well. However, the FDA doesn’t always approve drugs that pass a P3, there is always a risk until it’s over the finish line. I guess I have anxiety because of the “What can go wrong, will go wrong” history with this company. No need for name calling, just trying to generate meaningful discussion.